MedTrace Logo

PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program

NCT04190251 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2023-02-23

No results posted yet for this study

Summary

Monocentric, randomised, controlled and open study. Subjects will be included prospectively and consecutively and randomly assigned into two groups. Intervention group A will benefit a medication adherence support program during 12 months while intervention group B during 6 months only. Adherence will be monitored using an Electronic Monitoring system (EM, named MEMS®; Aardex Ltd.) during 24 months. At each pharmacy visit, the pharmacist will conduct a semi-structured interview in 15 minutes based on Fisher's sociocognitive model with the patients. A summary of the interview and the adherence graph will be send to the patient' health professionals.

Conditions

  • Diabetes Mellitus, Type 2
  • Renal Insufficiency, Chronic

Interventions

OTHER

Inteprofessional medication adherence support program (IMAP)

In addition to usual care, patients participate in a medication adherence support program combining an Electronic Monitoring system (EM, named MEMS®; Aardex Ltd) and motivational semi-structured interviews. This programm is done by the Unisanté's community pharmacists, in coordination with medical and nurse staff , to support medication adherence and to promote continuity of care. The intervention is held at the Unisanté's community pharmacy. For patients not speaking french, english, or italien, the interviews will be done with a interpreter.

Sponsors & Collaborators

  • pharmaSuisse

    collaborator UNKNOWN

  • santésuisse

    collaborator UNKNOWN

  • Curafutura

    collaborator UNKNOWN

  • Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

    lead OTHER

Principal Investigators

  • Marie-Paule Schneider, Prof. · Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

  • Carole Bandiera, PhD student · Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

  • Anne Zanchi, PhD-PD · CHUV (Centre hospitalier Universitaire Vaudois)

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-14
Primary Completion
2022-12-20
Completion
2022-12-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04190251 on ClinicalTrials.gov